Ann Arbor Stage IV Marginal Zone Lymphoma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB14681 | Cortisone | 1 | Active Not Recruiting | 1 |
| DB00531 | Cyclophosphamide | 1 | Active Not Recruiting | 1 |
| DB00997 | Doxorubicin | 1 | Active Not Recruiting | 1 |
| DB00099 | Filgrastim | 1 | Active Not Recruiting | 1 |
| DB00959 | Methylprednisolone | 1 | Active Not Recruiting | 1 |
| DB14867 | Parsaclisib | 1 | Active Not Recruiting | 1 |
| DB00019 | Pegfilgrastim | 1 | Active Not Recruiting | 1 |
| DB12240 | Polatuzumab vedotin | 1 | Active Not Recruiting | 1 |
| DB00635 | Prednisone | 1 | Active Not Recruiting | 1 |
| DB00073 | Rituximab | 1 | Active Not Recruiting | 1 |
| DB14546 | Sulfate ion | 1 | Active Not Recruiting | 1 |
| DB00541 | Vincristine | 1 | Active Not Recruiting | 1 |
| DB17573 | Evorpacept | 1 / 2 | Recruiting | 1 |
| DB00480 | Lenalidomide | 1 / 2 | Recruiting | 1 |
| DB00073 | Rituximab | 1 / 2 | Recruiting | 1 |
| DB09053 | Ibrutinib | 2 | Completed | 1 |
| DB00480 | Lenalidomide | 2 | Completed | 2 |
| DB00073 | Rituximab | 2 | Completed | 2 |